Global Approved COVID-19 Vaccines Market Growth 2025-2031

February 2025 | 89 pages | ID: GD53EC70ED85EN
LP Information

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Approved COVID-19 Vaccines Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Approved COVID-19 Vaccines by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Approved COVID-19 Vaccines by Country/Region, 2020, 2024 & 2031
2.2 Approved COVID-19 Vaccines Segment by Type
  2.2.1 Component Viral Vaccines
  2.2.2 Whole Virus Vaccines
2.3 Approved COVID-19 Vaccines Sales by Type
  2.3.1 Global Approved COVID-19 Vaccines Sales Market Share by Type (2020-2025)
  2.3.2 Global Approved COVID-19 Vaccines Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Approved COVID-19 Vaccines Sale Price by Type (2020-2025)
2.4 Approved COVID-19 Vaccines Segment by Application
  2.4.1 Adults
  2.4.2 Children
  2.4.3 Elderly
2.5 Approved COVID-19 Vaccines Sales by Application
  2.5.1 Global Approved COVID-19 Vaccines Sale Market Share by Application (2020-2025)
  2.5.2 Global Approved COVID-19 Vaccines Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Approved COVID-19 Vaccines Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Approved COVID-19 Vaccines Breakdown Data by Company
  3.1.1 Global Approved COVID-19 Vaccines Annual Sales by Company (2020-2025)
  3.1.2 Global Approved COVID-19 Vaccines Sales Market Share by Company (2020-2025)
3.2 Global Approved COVID-19 Vaccines Annual Revenue by Company (2020-2025)
  3.2.1 Global Approved COVID-19 Vaccines Revenue by Company (2020-2025)
  3.2.2 Global Approved COVID-19 Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global Approved COVID-19 Vaccines Sale Price by Company
3.4 Key Manufacturers Approved COVID-19 Vaccines Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Approved COVID-19 Vaccines Product Location Distribution
  3.4.2 Players Approved COVID-19 Vaccines Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR APPROVED COVID-19 VACCINES BY GEOGRAPHIC REGION

4.1 World Historic Approved COVID-19 Vaccines Market Size by Geographic Region (2020-2025)
  4.1.1 Global Approved COVID-19 Vaccines Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Approved COVID-19 Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Approved COVID-19 Vaccines Market Size by Country/Region (2020-2025)
  4.2.1 Global Approved COVID-19 Vaccines Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Approved COVID-19 Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Approved COVID-19 Vaccines Sales Growth
4.4 APAC Approved COVID-19 Vaccines Sales Growth
4.5 Europe Approved COVID-19 Vaccines Sales Growth
4.6 Middle East & Africa Approved COVID-19 Vaccines Sales Growth

5 AMERICAS

5.1 Americas Approved COVID-19 Vaccines Sales by Country
  5.1.1 Americas Approved COVID-19 Vaccines Sales by Country (2020-2025)
  5.1.2 Americas Approved COVID-19 Vaccines Revenue by Country (2020-2025)
5.2 Americas Approved COVID-19 Vaccines Sales by Type (2020-2025)
5.3 Americas Approved COVID-19 Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Approved COVID-19 Vaccines Sales by Region
  6.1.1 APAC Approved COVID-19 Vaccines Sales by Region (2020-2025)
  6.1.2 APAC Approved COVID-19 Vaccines Revenue by Region (2020-2025)
6.2 APAC Approved COVID-19 Vaccines Sales by Type (2020-2025)
6.3 APAC Approved COVID-19 Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Approved COVID-19 Vaccines by Country
  7.1.1 Europe Approved COVID-19 Vaccines Sales by Country (2020-2025)
  7.1.2 Europe Approved COVID-19 Vaccines Revenue by Country (2020-2025)
7.2 Europe Approved COVID-19 Vaccines Sales by Type (2020-2025)
7.3 Europe Approved COVID-19 Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Approved COVID-19 Vaccines by Country
  8.1.1 Middle East & Africa Approved COVID-19 Vaccines Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Approved COVID-19 Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa Approved COVID-19 Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa Approved COVID-19 Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Approved COVID-19 Vaccines
10.3 Manufacturing Process Analysis of Approved COVID-19 Vaccines
10.4 Industry Chain Structure of Approved COVID-19 Vaccines

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Approved COVID-19 Vaccines Distributors
11.3 Approved COVID-19 Vaccines Customer

12 WORLD FORECAST REVIEW FOR APPROVED COVID-19 VACCINES BY GEOGRAPHIC REGION

12.1 Global Approved COVID-19 Vaccines Market Size Forecast by Region
  12.1.1 Global Approved COVID-19 Vaccines Forecast by Region (2026-2031)
  12.1.2 Global Approved COVID-19 Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Approved COVID-19 Vaccines Forecast by Type (2026-2031)
12.7 Global Approved COVID-19 Vaccines Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Moderna
  13.1.1 Moderna Company Information
  13.1.2 Moderna Approved COVID-19 Vaccines Product Portfolios and Specifications
  13.1.3 Moderna Approved COVID-19 Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Moderna Main Business Overview
  13.1.5 Moderna Latest Developments
13.2 CanSino Biologicals
  13.2.1 CanSino Biologicals Company Information
  13.2.2 CanSino Biologicals Approved COVID-19 Vaccines Product Portfolios and Specifications
  13.2.3 CanSino Biologicals Approved COVID-19 Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 CanSino Biologicals Main Business Overview
  13.2.5 CanSino Biologicals Latest Developments
13.3 Inovio Pharmaceuticals
  13.3.1 Inovio Pharmaceuticals Company Information
  13.3.2 Inovio Pharmaceuticals Approved COVID-19 Vaccines Product Portfolios and Specifications
  13.3.3 Inovio Pharmaceuticals Approved COVID-19 Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Inovio Pharmaceuticals Main Business Overview
  13.3.5 Inovio Pharmaceuticals Latest Developments
13.4 Shenzhen Geno-Immune Medical Institute
  13.4.1 Shenzhen Geno-Immune Medical Institute Company Information
  13.4.2 Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Product Portfolios and Specifications
  13.4.3 Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Shenzhen Geno-Immune Medical Institute Main Business Overview
  13.4.5 Shenzhen Geno-Immune Medical Institute Latest Developments
13.5 GlaxoSmithKine
  13.5.1 GlaxoSmithKine Company Information
  13.5.2 GlaxoSmithKine Approved COVID-19 Vaccines Product Portfolios and Specifications
  13.5.3 GlaxoSmithKine Approved COVID-19 Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 GlaxoSmithKine Main Business Overview
  13.5.5 GlaxoSmithKine Latest Developments
13.6 Pfizer
  13.6.1 Pfizer Company Information
  13.6.2 Pfizer Approved COVID-19 Vaccines Product Portfolios and Specifications
  13.6.3 Pfizer Approved COVID-19 Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Pfizer Main Business Overview
  13.6.5 Pfizer Latest Developments
13.7 Johnson?Johnson
  13.7.1 Johnson?Johnson Company Information
  13.7.2 Johnson?Johnson Approved COVID-19 Vaccines Product Portfolios and Specifications
  13.7.3 Johnson?Johnson Approved COVID-19 Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Johnson?Johnson Main Business Overview
  13.7.5 Johnson?Johnson Latest Developments
13.8 Heat Biologics
  13.8.1 Heat Biologics Company Information
  13.8.2 Heat Biologics Approved COVID-19 Vaccines Product Portfolios and Specifications
  13.8.3 Heat Biologics Approved COVID-19 Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Heat Biologics Main Business Overview
  13.8.5 Heat Biologics Latest Developments
13.9 Sanofi
  13.9.1 Sanofi Company Information
  13.9.2 Sanofi Approved COVID-19 Vaccines Product Portfolios and Specifications
  13.9.3 Sanofi Approved COVID-19 Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Sanofi Main Business Overview
  13.9.5 Sanofi Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Approved COVID-19 Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Approved COVID-19 Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Component Viral Vaccines
Table 4. Major Players of Whole Virus Vaccines
Table 5. Global Approved COVID-19 Vaccines Sales byType (2020-2025) & (K Units)
Table 6. Global Approved COVID-19 Vaccines Sales Market Share byType (2020-2025)
Table 7. Global Approved COVID-19 Vaccines Revenue byType (2020-2025) & ($ million)
Table 8. Global Approved COVID-19 Vaccines Revenue Market Share byType (2020-2025)
Table 9. Global Approved COVID-19 Vaccines Sale Price byType (2020-2025) & (US$/Unit)
Table 10. Global Approved COVID-19 Vaccines Sale by Application (2020-2025) & (K Units)
Table 11. Global Approved COVID-19 Vaccines Sale Market Share by Application (2020-2025)
Table 12. Global Approved COVID-19 Vaccines Revenue by Application (2020-2025) & ($ million)
Table 13. Global Approved COVID-19 Vaccines Revenue Market Share by Application (2020-2025)
Table 14. Global Approved COVID-19 Vaccines Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global Approved COVID-19 Vaccines Sales by Company (2020-2025) & (K Units)
Table 16. Global Approved COVID-19 Vaccines Sales Market Share by Company (2020-2025)
Table 17. Global Approved COVID-19 Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Approved COVID-19 Vaccines Revenue Market Share by Company (2020-2025)
Table 19. Global Approved COVID-19 Vaccines Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers Approved COVID-19 Vaccines Producing Area Distribution and Sales Area
Table 21. Players Approved COVID-19 Vaccines Products Offered
Table 22. Approved COVID-19 Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Approved COVID-19 Vaccines Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Approved COVID-19 Vaccines Sales Market Share Geographic Region (2020-2025)
Table 27. Global Approved COVID-19 Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Approved COVID-19 Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Approved COVID-19 Vaccines Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Approved COVID-19 Vaccines Sales Market Share by Country/Region (2020-2025)
Table 31. Global Approved COVID-19 Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Approved COVID-19 Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Approved COVID-19 Vaccines Sales by Country (2020-2025) & (K Units)
Table 34. Americas Approved COVID-19 Vaccines Sales Market Share by Country (2020-2025)
Table 35. Americas Approved COVID-19 Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Approved COVID-19 Vaccines Sales byType (2020-2025) & (K Units)
Table 37. Americas Approved COVID-19 Vaccines Sales by Application (2020-2025) & (K Units)
Table 38. APAC Approved COVID-19 Vaccines Sales by Region (2020-2025) & (K Units)
Table 39. APAC Approved COVID-19 Vaccines Sales Market Share by Region (2020-2025)
Table 40. APAC Approved COVID-19 Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Approved COVID-19 Vaccines Sales byType (2020-2025) & (K Units)
Table 42. APAC Approved COVID-19 Vaccines Sales by Application (2020-2025) & (K Units)
Table 43. Europe Approved COVID-19 Vaccines Sales by Country (2020-2025) & (K Units)
Table 44. Europe Approved COVID-19 Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Approved COVID-19 Vaccines Sales byType (2020-2025) & (K Units)
Table 46. Europe Approved COVID-19 Vaccines Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Approved COVID-19 Vaccines Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Approved COVID-19 Vaccines Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Approved COVID-19 Vaccines Sales byType (2020-2025) & (K Units)
Table 50. Middle East & Africa Approved COVID-19 Vaccines Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Approved COVID-19 Vaccines
Table 52. Key Market Challenges & Risks of Approved COVID-19 Vaccines
Table 53. Key IndustryTrends of Approved COVID-19 Vaccines
Table 54. Approved COVID-19 Vaccines Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Approved COVID-19 Vaccines Distributors List
Table 57. Approved COVID-19 Vaccines Customer List
Table 58. Global Approved COVID-19 Vaccines SalesForecast by Region (2026-2031) & (K Units)
Table 59. Global Approved COVID-19 Vaccines RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Approved COVID-19 Vaccines SalesForecast by Country (2026-2031) & (K Units)
Table 61. Americas Approved COVID-19 Vaccines Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Approved COVID-19 Vaccines SalesForecast by Region (2026-2031) & (K Units)
Table 63. APAC Approved COVID-19 Vaccines Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Approved COVID-19 Vaccines SalesForecast by Country (2026-2031) & (K Units)
Table 65. Europe Approved COVID-19 Vaccines RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Approved COVID-19 Vaccines SalesForecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Approved COVID-19 Vaccines RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Approved COVID-19 Vaccines SalesForecast byType (2026-2031) & (K Units)
Table 69. Global Approved COVID-19 Vaccines RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Approved COVID-19 Vaccines SalesForecast by Application (2026-2031) & (K Units)
Table 71. Global Approved COVID-19 Vaccines RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Moderna Basic Information, Approved COVID-19 Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 73. Moderna Approved COVID-19 Vaccines Product Portfolios and Specifications
Table 74. Moderna Approved COVID-19 Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Moderna Main Business
Table 76. Moderna Latest Developments
Table 77. CanSino Biologicals Basic Information, Approved COVID-19 Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 78. CanSino Biologicals Approved COVID-19 Vaccines Product Portfolios and Specifications
Table 79. CanSino Biologicals Approved COVID-19 Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. CanSino Biologicals Main Business
Table 81. CanSino Biologicals Latest Developments
Table 82. Inovio Pharmaceuticals Basic Information, Approved COVID-19 Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 83. Inovio Pharmaceuticals Approved COVID-19 Vaccines Product Portfolios and Specifications
Table 84. Inovio Pharmaceuticals Approved COVID-19 Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Inovio Pharmaceuticals Main Business
Table 86. Inovio Pharmaceuticals Latest Developments
Table 87. Shenzhen Geno-Immune Medical Institute Basic Information, Approved COVID-19 Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 88. Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Product Portfolios and Specifications
Table 89. Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Shenzhen Geno-Immune Medical Institute Main Business
Table 91. Shenzhen Geno-Immune Medical Institute Latest Developments
Table 92. GlaxoSmithKine Basic Information, Approved COVID-19 Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 93. GlaxoSmithKine Approved COVID-19 Vaccines Product Portfolios and Specifications
Table 94. GlaxoSmithKine Approved COVID-19 Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. GlaxoSmithKine Main Business
Table 96. GlaxoSmithKine Latest Developments
Table 97. Pfizer Basic Information, Approved COVID-19 Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 98. Pfizer Approved COVID-19 Vaccines Product Portfolios and Specifications
Table 99. Pfizer Approved COVID-19 Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Pfizer Main Business
Table 101. Pfizer Latest Developments
Table 102. Johnson?Johnson Basic Information, Approved COVID-19 Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 103. Johnson?Johnson Approved COVID-19 Vaccines Product Portfolios and Specifications
Table 104. Johnson?Johnson Approved COVID-19 Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Johnson?Johnson Main Business
Table 106. Johnson?Johnson Latest Developments
Table 107. Heat Biologics Basic Information, Approved COVID-19 Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 108. Heat Biologics Approved COVID-19 Vaccines Product Portfolios and Specifications
Table 109. Heat Biologics Approved COVID-19 Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Heat Biologics Main Business
Table 111. Heat Biologics Latest Developments
Table 112. Sanofi Basic Information, Approved COVID-19 Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 113. Sanofi Approved COVID-19 Vaccines Product Portfolios and Specifications
Table 114. Sanofi Approved COVID-19 Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. Sanofi Main Business
Table 116. Sanofi Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Approved COVID-19 Vaccines
Figure 2. Approved COVID-19 Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Approved COVID-19 Vaccines Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Approved COVID-19 Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Approved COVID-19 Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Approved COVID-19 Vaccines Sales Market Share by Country/Region (2024)
Figure 10. Approved COVID-19 Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Component Viral Vaccines
Figure 12. Product Picture of Whole Virus Vaccines
Figure 13. Global Approved COVID-19 Vaccines Sales Market Share byType in 2025
Figure 14. Global Approved COVID-19 Vaccines Revenue Market Share byType (2020-2025)
Figure 15. Approved COVID-19 Vaccines Consumed in Adults
Figure 16. Global Approved COVID-19 Vaccines Market: Adults (2020-2025) & (K Units)
Figure 17. Approved COVID-19 Vaccines Consumed in Children
Figure 18. Global Approved COVID-19 Vaccines Market: Children (2020-2025) & (K Units)
Figure 19. Approved COVID-19 Vaccines Consumed in Elderly
Figure 20. Global Approved COVID-19 Vaccines Market: Elderly (2020-2025) & (K Units)
Figure 21. Global Approved COVID-19 Vaccines Sale Market Share by Application (2024)
Figure 22. Global Approved COVID-19 Vaccines Revenue Market Share by Application in 2025
Figure 23. Approved COVID-19 Vaccines Sales by Company in 2025 (K Units)
Figure 24. Global Approved COVID-19 Vaccines Sales Market Share by Company in 2025
Figure 25. Approved COVID-19 Vaccines Revenue by Company in 2025 ($ millions)
Figure 26. Global Approved COVID-19 Vaccines Revenue Market Share by Company in 2025
Figure 27. Global Approved COVID-19 Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Approved COVID-19 Vaccines Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Approved COVID-19 Vaccines Sales 2020-2025 (K Units)
Figure 30. Americas Approved COVID-19 Vaccines Revenue 2020-2025 ($ millions)
Figure 31. APAC Approved COVID-19 Vaccines Sales 2020-2025 (K Units)
Figure 32. APAC Approved COVID-19 Vaccines Revenue 2020-2025 ($ millions)
Figure 33. Europe Approved COVID-19 Vaccines Sales 2020-2025 (K Units)
Figure 34. Europe Approved COVID-19 Vaccines Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Approved COVID-19 Vaccines Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Approved COVID-19 Vaccines Revenue 2020-2025 ($ millions)
Figure 37. Americas Approved COVID-19 Vaccines Sales Market Share by Country in 2025
Figure 38. Americas Approved COVID-19 Vaccines Revenue Market Share by Country (2020-2025)
Figure 39. Americas Approved COVID-19 Vaccines Sales Market Share byType (2020-2025)
Figure 40. Americas Approved COVID-19 Vaccines Sales Market Share by Application (2020-2025)
Figure 41. United States Approved COVID-19 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Approved COVID-19 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Approved COVID-19 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Approved COVID-19 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Approved COVID-19 Vaccines Sales Market Share by Region in 2025
Figure 46. APAC Approved COVID-19 Vaccines Revenue Market Share by Region (2020-2025)
Figure 47. APAC Approved COVID-19 Vaccines Sales Market Share byType (2020-2025)
Figure 48. APAC Approved COVID-19 Vaccines Sales Market Share by Application (2020-2025)
Figure 49. China Approved COVID-19 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Approved COVID-19 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Approved COVID-19 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Approved COVID-19 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 53. India Approved COVID-19 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Approved COVID-19 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan Approved COVID-19 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Approved COVID-19 Vaccines Sales Market Share by Country in 2025
Figure 57. Europe Approved COVID-19 Vaccines Revenue Market Share by Country (2020-2025)
Figure 58. Europe Approved COVID-19 Vaccines Sales Market Share byType (2020-2025)
Figure 59. Europe Approved COVID-19 Vaccines Sales Market Share by Application (2020-2025)
Figure 60. Germany Approved COVID-19 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 61.France Approved COVID-19 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Approved COVID-19 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Approved COVID-19 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Approved COVID-19 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Approved COVID-19 Vaccines Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Approved COVID-19 Vaccines Sales Market Share byType (2020-2025)
Figure 67. Middle East & Africa Approved COVID-19 Vaccines Sales Market Share by Application (2020-2025)
Figure 68. Egypt Approved COVID-19 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Approved COVID-19 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Approved COVID-19 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey Approved COVID-19 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Approved COVID-19 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Approved COVID-19 Vaccines in 2025
Figure 74. Manufacturing Process Analysis of Approved COVID-19 Vaccines
Figure 75. Industry Chain Structure of Approved COVID-19 Vaccines
Figure 76. Channels of Distribution
Figure 77. Global Approved COVID-19 Vaccines Sales MarketForecast by Region (2026-2031)
Figure 78. Global Approved COVID-19 Vaccines Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global Approved COVID-19 Vaccines Sales Market ShareForecast byType (2026-2031)
Figure 80. Global Approved COVID-19 Vaccines Revenue Market ShareForecast byType (2026-2031)
Figure 81. Global Approved COVID-19 Vaccines Sales Market ShareForecast by Application (2026-2031)
Figure 82. Global Approved COVID-19 Vaccines Revenue Market ShareForecast by Application (2026-2031)